The Touro College of Osteopathic Medicine (TouroCOM) is a private medical school with a main campus in the neighborhood of Central Harlem in New York City and an additional campus in Middletown, New York. It is a division of Touro College and University System. The college's inaugural class graduated in 2011. It was the first medical school to open in New York State in nearly 30 years and is the first osteopathic medical school with a special emphasis on training minority doctors. TouroCOM currently has a student body of about 1080 students.TouroCOM has a stated goal of particularly identifying and recruiting students willing to make a commitment to practice in underserved communities such as Harlem and Middletown. The neighborhood has been designated by the federal government as underserved by medical professionals. Community service events such as free health counseling, screenings, and flu shots are offered to local residents by students and faculty several times a year.
Recommendations concerning the language used to describe autism center primarily around preferences for person-first language (PFL; e.g., person with autism) or identity-first language (IFL; e.g.., autistic person). Empirical research on this topic has recently proliferated, yet there is no clear consensus. In this study, we systematically reviewed prior research on the autistic community’s language preferences. Our search generated 2483 articles. Nineteen studies (N = 6350) quantitatively assessed autistic people’s perspectives of autism language terms. We extracted data regarding most preferred terms and terms deemed acceptable for use. All studies were conducted online. Fourteen assessed preferred terminology; 10 found that more participants preferred IFL than PFL, though there was also considerable PFL endorsement (4–39
The platelet-rich plasma in achilles tendon healing 2 (PATH-2) trial is the largest randomized study of platelet-rich plasma (PRP) in acute Achilles tendon rupture. While the original frequentist analysis showed no significant benefit, such methods cannot quantify the probability of clinically meaningful improvement. We conducted a Bayesian re-analysis of PATH-2 data (n = 177) with Achilles tendon total rupture score (ATRS) and patient-specific functional scale (PSFS) at 24 months as outcomes. Minimally clinically important differences (MCIDs) were defined as 8 ATRS points and 2.3 PSFS points. Across flat, neutral, optimistic, and pessimistic priors, posterior probabilities of PRP providing benefit ≥MCID were <0.001% for ATRS and ~5×10-13 for PSFS. Probabilities of any benefit were 39.6% and 47.0%, respectively, with posterior mean differences close to zero. Results were robust across priors. This analysis demonstrates that PRP is unlikely to yield clinically meaningful functional improvement after Achilles tendon rupture.
Graph Neural Networks (GNNs) have emerged as a novel paradigm that enables scientists to model complex relational data in medical applications, offering unique advantages over traditional deep learning (DL) approaches for non-Euclidean domains. This paper provides a comprehensive review of current GNN architectures and their healthcare applications, with a focus on functional connectivity analysis, electrical-based diagnostics, and anatomical structure modeling. We analyze the strengths and limitations of spectral and spatial GNN variants, including Graph Convolutional Networks (GCNs), Graph Attention Networks (GATs), and spatio-temporal extensions. Based on our critical assessment of the state-of-the-art innovations, we propose several key directions for medical researchers actively developing GNN technology: (1) Dynamic graph representation learning to capture evolving physiological processes; (2) Multi-modal fusion techniques to integrate heterogeneous biomedical data streams; (3) Uncertainty-aware GNNs for robust clinical decision support; (4) Explainable GNN architectures to enhance interpretability for healthcare practitioners; and (5) Federated GNN frameworks to enable privacy-preserving collaborative learning across institutions. We also introduce a new Temporal Multi-modal Attention Graph Neural Network (TMA-GNN) architecture designed explicitly for longitudinal patient modeling and clinical trial optimization. Our TMA-GNN incorporates multi-head attention mechanisms, temporal edge construction, and a custom loss function to encourage temporal consistency in predictions. We introduce a conceptual framework for the Temporal Multi-modal Attention Graph Neural Network (TMA-GNN), which is designed to support disease progression modeling and clinical trial optimization in neurological disorders. Although the proposed model architecture is technically detailed, this manuscript focuses on the conceptual and methodological design, rather than presenting experimental results. By addressing these proposed research directions, we envision GNNs will play an increasingly pivotal role in precision medicine, disease progression modeling, and treatment personalization.
Objectives Pediatric intestinal pseudo-obstruction (PIPO) is a severe bowel motility disorder characterized by impaired propulsion of gastrointestinal contents without mechanical obstruction. PIPO encompasses congenital and acquired disorders, including neuropathies, myopathies, and mesenchymopathies. PIPO presents with abdominal distension, bilious vomiting, and severe constipation. Diagnosis is based on objective measures of neuromuscular dysfunction, dilated bowel on imaging, parenteral and/or enteral nutrition dependence, and genetic or metabolic testing. Antroduodenal manometry permits objective assessment of proximal bowel neuromuscular function. Genetic testing is increasingly valuable although causes of PIPO often remain incompletely defined. Understanding genotype-phenotype correlations is essential for clarifying disease mechanisms and guiding therapies. This study aimed to characterize the clinical and genetic profiles of children with PIPO, utilizing manometric data for subtype classification.Methods A retrospective chart review was conducted at a tertiary care pediatric medical center, with inclusion criteria of PIPO diagnosis, completed manometry testing, and genetic evaluation.Results Nineteen children met inclusion criteria. Antroduodenal manometry classified 59% as neuropathic, 35% as myopathic, and one with mixed neuropathic and myopathic dysfunction. Genetic testing revealed pathogenic ACTG2 mutations in all myopathic cases, while neuropathic PIPO exhibited more genetic variability. Histopathology was inconsistent and often nonspecific. Therapeutic approaches focused on nutritional support and promotility agents, with surgical intervention more common in myopathic cases.Conclusions This study highlights the association of ACTG2 mutations with a myopathic phenotype, and genetic diversity in neuropathic PIPO, emphasizing the need for further research to improve phenotyping to enhance diagnosis and treatment.
OBJECTIVE:To evaluate the association between race and severe maternal morbidity (SMM) in delivery hospitalizations with polycystic ovarian syndrome (PCOS). DESIGN:Retrospective cross-sectional study using the Nationwide Inpatient Sample (Q4 2015-2019). SMM was defined by the CDC algorithm of 21 ICD-10 indicators. Multivariable logistic regression assessed associations between race and SMM, adjusting for demographics, insurance, hospital type, obesity, hypertension, and diabetes. SUBJECTS:Delivery hospitalizations with PCOS (ICD-10 E28.2). RESULTS:Of 3.1 million deliveries, 19,962 (0.64%) had PCOS; 444 (2.22%) experienced SMM. Patients were predominantly White (66.7%) and <35 years (76.9%). Common comorbidities included obesity (30.2%), hypertension (9.5%), and diabetes (5.1%). Unadjusted analyses showed the highest SMM among Black (3.4%), Native American/Other (3.0%), and Asian/Pacific Islander (2.7%) patients. SMM was also more common among those ≥35 years, with public insurance, and at urban teaching hospitals. In adjusted models, Native American/Other (adjusted odds ratio [AOR] 1.44, 95% confidence interval [CI] 1.07-1.92), Black (AOR 1.42, 95% CI 1.11-1.81), and Asian/Pacific Islander (AOR 1.40, 95% CI 1.07-1.83) patients had significantly higher odds of SMM compared with White patients. Additional predictors included age ≥35 years (AOR 1.54, 95% CI 1.31-1.80), obesity (AOR 1.19, 95% CI 1.01-1.39), hypertension (AOR 1.65, 95% CI 1.32-2.04), and public insurance (AOR 1.35, 95% CI 1.14-1.60). Urban nonteaching hospitals (AOR 0.63, 95% CI 0.50-0.79) and Midwest hospital region (AOR 0.76, 95% CI 0.62-0.93) were associated with reduced odds of SMM. CONCLUSION:Racial disparities in SMM persisted among patients with PCOS despite adjustment for comorbidities and hospital factors. Race-conscious prenatal care and structural interventions are needed to reduce inequities.